Management of hand tremor in Primary care setting. Specialist in Family Medicine
|
|
- Alyson Dorsey
- 7 years ago
- Views:
Transcription
1 Management of hand tremor in Primary care setting Dr. Ko Wai Kit, Welchie Specialist in Family Medicine
2
3
4 Types of hand tremor Causes of hand tremor How to approach a hand tremor patient Management of common causes of hand tremor When to refer?
5 Definition of Tremor Any abnormal repetitive shaking movement of the body
6 Types of hand tremor Causes of hand tremor How to approach a hand tremor patient Management of common causes of hand tremor When to refer?
7 Types of Tremor Resting Tremor Postural Tremor Intention Tremor Flapping Tremor
8 Resting tremor Tremor present at rest Most marked with the arms supported on the lap and during walking Decrease in finger-nose nose test Character: pill-rolling movement of the fingers at the metacarpophalangeal joints is combined with movement of thumb
9 Postural tremor Fine tremor Tremor noted with the arms outstretched and finger apart More obvious if a sheet of paper is placed over the dorsum of hands
10 Intention tremor Coarse oscillating tremor Exacerbated by action and increase as the target is approached Absent at rest Test: finger-nose nose touching
11 Flapping tremor Observed when the arms are extended with hyperextension of wrists Character: slow, coarse and jerky movement of flexion and extension at the wrist
12 Types of hand tremor Causes of hand tremor How to approach a hand tremor patient Management of common causes of hand tremor When to refer?
13 Causes of tremor Resting tremor Parkinsonism Postural tremor Physiological Anxiety / emotional Alcohol Hyperthyroidism Essential tremor Drugs Phaeochromocytoma
14 Intention tremor Cerebellar lesion Flapping tremor Wilson s s disease Hepatic encephalopathy Uraemia Respiratory failure Lesion of the red nucleus of the midbrain
15 Parkinsonism Most common cause: Parkinson s disease (PD) A neurodegenerative disease of unknown cause. Cause progressive disability and increases the mortality rate by 3 to 5 times
16 Epidemiology Common among older people (usu. After age of 50 years) ~ 1% adult >65 years Male to Female ratio: 3:2
17 Pathophysiology Loss of pigmented dopaminergic neurons (>2/3 before symptoms appear) and presence of Lewy bodies in the substantia nigra pars compacta Reduce dopamine content => =>overactive of subthalamic nucleous-globus pallidus-sn pars reticulata complex => =>inhibits the projection to motor cortex through thalamus
18 Dopaminergic pathways of the human brain in normal condition (left) and Parkinson's disease (right). Red Arrows indicate suppression of the target, blue arrows indicate stimulation of target structure.
19 Etiology Multifactorial Genetic; environmental toxin and aging 2-33 fold higher risk in first-degree relatives of PD (esp. for young onset <50 years)
20 Clinical features Insidious onset, involve one side initially but the other side also involve as the disease progress. Triad of classical symptoms: Resting tremor pill rolling Bradykinesia (may complaint as difficult in walking or leg weakness) Rigidity cogwheel rigidity
21 Other features: Mask face Stoop posture Gait: Shuffling, festinant,, poor arm swinging Monotonous and soft speech Micrographia Retropulsion (fall backward easily when pushed) Freezing (late feature, sudden transient inability to move when initiating walking and turning) Frequent fall Glabellar tap +ve+
22 DDx of Parkinson s s disease Secondary Vascular Drug induced e.g. neuroleptics Toxin e.g. MPTP, Manganese, cyanide Trauma e.g. Boxer s s injury Infection e.g. posttyphoid fever, AIDS Parkinson-plus syndrome Multiple system atrophy e.g. Shy-Drager syndrome Heredodegenerative Wilson s s disease
23 Hyperthyroidism Most common causes: Graves disease Toxic multinodular goiter Other less common causes: Subacute thyroiditis Thyroid caricinoma
24 Graves disease Autoimmune disorder present of stimulating immunoglobulin G antiboidies to the TSH receptor of thyroid follicular cell (TRAb( TRAb) Familial predisposition Male:Female ration 1:9 Onset 20 to 40 (in Asia)
25 Toxic nodular Goiter Unknown etiology Usu. In older patients May related to Iodine deficiency
26 Clinical features Can affect any organs Most common presentation: Hand tremor Weight loss Fatigue Heat intolerance Sweating Palpitation Nervous Diarrhoea
27 Common Signs Tachycardia / Atrial Fibrillation Postural hand tremor Goiter +/- bruit Lid retraction, Lid lag Exophthalmos
28 Investigations TSH FT4 FT3 Anti-TG TG Thyroid Thyroid globulin antibody Anti-TM TM--thyroid microsomal antibody
29 Essential tremor Autosomal dominant disorder (variable penetrance) Onset peaks bimodally in the teens and 50s Insidious onset with slow progression Start in one hand then spread to other with time Interferes with writing and handling Worse while arms held out Exacerbated by anxiety May affect other parts of body included head, chin, tongue, legs and speech Relieved by alcohol
30 Triad of features Positive family History Tremor with little disability Normal gait
31 Common medication causing hand tremor Caffeine Beta-adrenergic adrenergic agonist e.g. ventolin Hypoglycaemic agent Pseudoephedine Theophylline Thyroxine Antidepression: : TCA, Prozac Tegretal Haldol Lithium Alcohol withdraw or chronic alcoholism
32 Types of hand tremor Causes of hand tremor How to approach a hand tremor patient Management of common causes of hand tremor When to refer?
33 How to approach a hand tremor History taking: patient Description of the tremor Nature Involved body parts Onset Course and progression Precipitating factor / relieving factor How the symptom affecting the patient s s life
34 Other related symptoms Included systemic review Idea / Concern / Expectation (ICE) Past Medical history (included current medications) Family History Psychosocial History Drug allergy
35 Physical examinations: Check for the hand tremor Check other signs according to the provisional diagnosis
36
37 Types of hand tremor Causes of hand tremor How to approach a hand tremor patient Management of common causes of hand tremor When to refer?
38 Management of Common causes of hand tremor Parkinson s s disease Essential tremor Hyperthyroidism
39 Management for Parkinsonism Treatment principle: Treatment should be individualized according to patient s s functional impairment, age, stages of disease and response Current medications are effective in control symptoms but not neuroprotective Medication only start when symptoms are disabling
40 Non-pharmacological treatment Provide appropriate explanation and education Support group 香 港 柏 金 遜 症 會 Tel: Physiotherapy Physical Aids e.g. walking stick
41 Pharmacological treatment Levodopa Dopamine agonist Selegiline Catechol-O-Methyltransferase (COMT) inhibitors Anticholinergic drugs Amantadine
42 Levodopa Immediate precursor of dopamine to correct striatal dopamine deficiency Add peripheral decarboxylase inhibitor e.g. Benserazide and carbidopa)=>prevent peripheral dopaminergic side effect such as nausea and hypotension Common drug use: Sinemet (levodopa/carbidop) Madopar (Levodopa/Benserazide)
43 Side Effect & Precaution Side effect while prolong use: Wearing off : : gradual shortening of drug effect Peak dose Dyskinesia: : chorea after each dose of levodopa Toxic to dopaminergic neuron Precaution: Delay levodopa therapy as possible esp. for younger patient
44 Dopamine agonist Direct stimulate striatal dopamine receptors Lower risk of motor complications Advice for young patient with mild symptom Use as initial monotherapy or adjunctive to Levodopa during wearing off SE: nausea, hypotension, hallucination and sleep attacks Cautious use for elderly patient Common drug use: Bromocriptine; Pergolide; Pramipexole
45 Selegiline Monoamine oxidase B inhibitor=>prevent dopamine metabolism by MAO Can prolong half-life life of levodopa Use as initial therapy or adjunctive Common drug use: Deprenyl
46 COMT inhibitor Prevent metabolize of levodopa=>prolong half-life life As adjunct in severe wearing-off complication Common drug use: Comtan
47 Anticholinergic drug Antagonizing uninhibited striatal cholinergic neurons Only for treating resting tremor SE: Dry mouth, blurred vision, urinary retention, constipation and confusion in elderly Not recommend for older patient >60 Common drug use: Artane
48 Amantadine With anticholinergic, dopaminergic and antiglutaminergic effects Use as initial treatment or adjunctive Reduce levodopa-induced dyskinesia in high dose
49 Surgical treatment Only for severe disabling symptoms refractory to medical treatment Destroy or inhibit abnormally discharging nuclei
50 Management for Essential Tremor Appropriate explanation is sufficient in most cases Alcohol before activity may help Maintenance vs intermittent therapy Medication therapy ~ 75% response: Propranolol Primidone
51 Propanolol Prefer for younger patient (increase risk of serious SE in elderly) Starting dose 20mg daily, max 320 mg/d
52 Primidone Anticonvulsant agent Prefer for older patient Initial dose 12.5/25mg at bedtime, max 1000mg/d Common SE (usu. in first dose): sedation, ataxia, vertigo, dizziness, nausea, vomiting, diplopia,, and nystagmus
53 Management of hyperthyroidism Antithyroid drugs Carbimazole Propylthiouracil (PTU) Radioactive Iodine (I 131 Subtotal thyroidectomy 131 )
54 Antithyroid drug Carbimazole and Propylthiouracil Mechanism: reduce thyroid hormone synthesis by inhibiting Iodine organification and iodotyrosyl coupling 40% relapse within 2 years after stopping therapy
55 Carbimazole Starting dose: 20-40mg/d Maintenance dose: 5-15mg/d5 SE: Hypersensitivity reaction (rash, pruritus and fever) Agranulocytosis (onset (onset within 3 mths,, recover within 2 weeks after stopped medication) Avoid in pregnancy
56 Propylthiouracil (PTU) Starting dose: mg/d Maintenance dose: mg/d SE: Hepatic necrosis (rare) Preferred during pregnancy and lactation (lesser cross placenta and secrete into breast milk)
57 Radioactive Iodine (I 131 ) Indication: 1. Recurrence after antithyroid drug 2. Poor drug compliance 3. Not tolerate SE of medication 50-70% resolve after single dose % develop hypothyroidism in 1 year, increase 2-4% 2 per subsequent years Contraindication: Pregnancy Confirm not pregnant before treatment and at least 4 months afterward
58 Indication: Thyroidectomy Large goiter with pressure symptoms Complications (<1%) Haemorrhage Recurrent laryngeal nerve palsy Hypoparathyroidism Rate of Hypothyroidism: 1% per year
59 Types of hand tremor Causes of hand tremor How to approach a hand tremor patient Management of common causes of hand tremor When to refer?
60 When to refer Not feel comfortable for further management Diagnosis is unclear at the initial presentation Treatment failure Develop complications
61 Take Home Message 1. Hand tremor Parkinsonism 2. Tailor make management plan for each patient 3. Treat your patient while feel comfortable, otherwise refer
62
Parkinson's s disease - a
Parkinson's Disease Parkinson's s disease - a progressive disorder of the nervous system that affects movement. The most common perception of Parkinson s is the patient having tremors. Hands shaking, inability
More informationChapter 28. Drug Treatment of Parkinson s Disease
Chapter 28 Drug Treatment of Parkinson s Disease 1. Introduction Parkinsonism Tremors hands and head develop involuntary movements when at rest; pin rolling sign (finger and thumb) Muscle rigidity arthritis
More informationParkinson s Disease - A Junior Doctor s Survival Guide
Parkinson s Disease - A Junior Doctor s Survival Guide Professor Richard Walker Consultant Geriatrician Hon. Professor of Ageing & Interna
More informationCENTRAL NERVOUS SYSTEM MANAGEMENT OF PARKINSON S DISEASE
MANAGEMENT CENTRAL NERVOUS SYSTEM MANAGEMENT OF PARKINSON S DISEASE Parkinson s Disease is classically determined by the triad or rest tremor (usually starting in one arm) with bradykinesia (slowing of
More informationPARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS
PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS De Anna Looper, RN CHPN Corporate Clinical Consultant / Legal Nurse Consultant Carrefour Associates L.L.C. PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS
More informationUnderstanding Parkinson s Disease
Understanding Parkinson s Disease Irene Oh, MD Neurologist, Movement Disorders Specialist The Neurology Center of Southern California, Encinitas & Escondido Introduction PD was first described in 1817
More informationWhat is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician
What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician Overview of presentation Case history Video example pre and post treatment Historical review PD in the UK Epidemiology and aetiology Making
More informationThe majority of parkinsonism (approx. 80%) is due to idiopathic PD other causes include drug therapy (Table 1),toxins and trauma.
THE TREATMENT OF PARKINSON S DISEASE SUMMARY Levodopa (L-dopa) administered in conjunction with a dopa decarboxylase inhibitor (DDCI) remains the mainstay of therapy for Parkinson s disease. New drugs
More informationGLOSSARY OF TERMS. This glossary explains the terms and words often used in association with Parkinson s.
Antagonist This glossary explains the terms and words often used in association with Parkinson s. Medications which have a negative effect on particular cells in the body. In Parkinson s dopamine antagonists
More informationABC s of Parkinson s Disease 4/29/15 Karen Parenti, MS, PsyD
ABC s of Parkinson s Disease 4/29/15 Karen Parenti, MS, PsyD What is Parkinson s Disease? Parkinson's disease is a progressive disorder of the nervous system that affects movement. It develops gradually,
More informationAnti-Parkinsonism Drugs
Anti-Parkinsonism Drugs Pharma Team 429 Fahad Alrumaih Ibrahim Alshiddi Sultan Alsalem Ismail Raslan Suhail Asiri Parkinsonism - Could be: primary [idiopathic] or secondary [viral infection or drug induced
More informationClinical Psychopharmacology
Clinical Psychopharmacology Antiparkinsonian drugs Department of Pharmacy, GGZ WNB Chair on Pharmacotherapy in Psychiatric Patients/Anton Loonen May 2015 2 Basal ganglia diseases Parkinson s disease and
More informationDementia & Movement Disorders
Dementia & Movement Disorders A/Prof Michael Davis Geriatrician ACT Health & GSAHS ANU Medical School Eastern Dementia Network Aged and Dementia Care Symposium Bateman s Bay, 22 October 2010 Types of Dementia
More informationParkinson s Disease (PD)
Parkinson s Disease (PD) Parkinson s disease (PD) is a movement disorder that worsens over time. About 1 in 100 people older than 60 has Parkinson s. The exact cause of PD is still not known, but research
More informationManagement of Parkinson s Disease in Primary Care
Management of Parkinson s Disease in Primary Care Dr June Tan National University Hospital System (NUHS) Division of Neurology Senior Consultant Topics: Diagnosing PD Choice of medication in the de novo
More informationloving life YOUR GUIDE TO YOUR THYROID
loving life YOUR GUIDE TO YOUR THYROID one THE THYROID two HYPOTHYROIDISM three HYPERTHYROIDISM four TREATING HYPERTHYROIDISM five THYROID NODULES AND GOITRES one THE THYROID What is the thyroid? The thyroid
More informationThyroid Disorders. Hypothyroidism
1 There are a number of problems associated with the thyroid gland. Hypothyroidism, hyperthyroidism, and thyroid nodules will be presented here. The thyroid gland is located in the middle of the neck,
More informationSLEEP DIFFICULTIES AND PARKINSON S DISEASE Julie H. Carter, R.N., M.S., A.N.P.
SLEEP DIFFICULTIES AND PARKINSON S DISEASE Julie H. Carter, R.N., M.S., A.N.P. Problems with sleep are common in Parkinson s disease. They can sometimes interfere with quality of life. It is helpful to
More informationDoncaster & Bassetlaw Medicines Formulary
Doncaster & Bassetlaw Medicines Formulary Section 4.9: Drugs Used in Parkinsonism and related Disorders Co-Beneldopa 12.5/50, 25/100 and 50/200 (Madopar) Capsules Co-Beneldopa 12.5/50 and 25/100 Dispersible
More informationParkinson s Disease and Tremors
Parkinson s Disease and Tremors Current Strategies Leah Karliner, MD, MAS Division of General Internal Medicine Disclosures I have no conflicts of interest Parkinsonism neurological syndrome: Bradykinesia:
More informationPARKINSON S DISEASE INTRODUCTION. Parkinson s disease is defined as a disease of the nervous system that affects voluntary movement.
PARKINSON S DISEASE INTRODUCTION Parkinson s disease is a disorder of the brain and the nervous system. It is one of the more common neurological diseases in people over the age of 60, and it is more common
More informationPARKINSON S DISEASE AND PARKINSONISM. Dr Phil Wood Geriatrician, Waitemata DHB Clinical Unit Leader, Waikato DHB
PARKINSON S DISEASE AND PARKINSONISM Dr Phil Wood Geriatrician, Waitemata DHB Clinical Unit Leader, Waikato DHB OUTLINE Covering:- Why this is an important area of Medical and Psychiatric care The variety
More informationMr James Garrard University of Leicester May 2014
Parkinson s disease exemplifies the art and science of geriatric medicine. Introduction First described by Dr. James Parkinson in the classic essay The Shaking Palsy in 1817 (1), Parkinson s disease is
More informationWhat You Need to Know About Xenazine
Note to Healthcare Professionals: Please provide this guide to your patient or your patient s caregiver. What You Need to Know About Xenazine (tetrabenazine) Patient/Caregiver Counseling Guide This guide
More informationNeuropharmacology I Parkinson s Disease and Movement Disorders
Harvard-MIT Division of Health Sciences and Technology HST.151: Principles of Pharmocology Instructor: Dr. David Standaert Standaert 1 Neuropharmacology I Parkinson s Disease and Movement Disorders What
More informationThyroid Gland Disease. Zdeněk Fryšák 3rd Clinic of Internal Medicine Nephrology-Rheumatology-Endocrinology Faculty Hospital Olomouc
Thyroid Gland Disease Zdeněk Fryšák 3rd Clinic of Internal Medicine Nephrology-Rheumatology-Endocrinology Faculty Hospital Olomouc t 1/2 = 5-7d t 1/2 = < 24 hrs Normal Daily Thyroid Secretion Rate:
More informationRecognition and Treatment of Depression in Parkinson s Disease
Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,
More informationParkinson's disease. Definition. Symptoms
Parkinson's disease Definition Parkinson's disease is a progressive disorder of the nervous system that affects your movement. It develops gradually, sometimes starting with a barely noticeable tremor
More informationParkinson s Disease and Dementia. Dr N Samaniego Consultant Physician and Geriatrician
Parkinson s Disease and Dementia Dr N Samaniego Consultant Physician and Geriatrician Case 68 year old female. Off legs for a few months, O/E no neurological deficit. -Slowing down -Needs help with dressing,
More informationWhite, circular, biconvex, uncoated tablets with a score line on one side, plain on the other.
Nausicalm Cyclizine hydrochloride Ph. Eur. 50 mg Presentation White, circular, biconvex, uncoated tablets with a score line on one side, plain on the other. Uses Actions The active ingredient-cyclizine
More informationNEW PATIENT CLINICAL INFORMATION FORM. Booth Gardner Parkinson s Care & Movement Disorders Center Evergreen Neuroscience Institute
NEW PATIENT CLINICAL INFORMATION FORM Booth Gardner Parkinson s Care & Movement Disorders Center Evergreen Neuroscience Institute Date: Name: Referring Doctor: How did you hear about us? NWPF Your Physician:
More informationPatient Guide to Radioiodine Treatment For Thyrotoxicosis (Overactive Thyroid Gland or Hyperthyroidism)
Patient Guide to Radioiodine Treatment For Thyrotoxicosis (Overactive Thyroid Gland or Hyperthyroidism) Your doctor has referred you to Nuclear Medicine for treatment of your overactive thyroid gland.
More informationEverything You Ever Wanted to Know About the Thyroid
Everything You Ever Wanted to Know About the Thyroid (but were afraid to ask ) Caroline Messer, MD Board Certified Internist, Endocrinologist, and Physician Nutrition Specialist Topics Thyroid Nodules
More informationMovement Disorder Emergencies. Anne E. A. Constantino, MD Attending Neurologist Holy Cross Hospital Silver Spring, MD June 28, 2014
Movement Disorder Emergencies Anne E. A. Constantino, MD Attending Neurologist Holy Cross Hospital Silver Spring, MD June 28, 2014 Objectives Provide a working definition of movement disorder emergencies
More informationFollow-up Form B3: Evaluation Form Unified Parkinson s Disease Rating Scale (UPDRS 1 ) Motor Exam
phone: (206) 543-8637; fax: (206) 616-5927 e-mail: naccmail@u.washington.edu website: www.alz.washington.edu NACC Uniform Data Set (UDS) Follow-up Form B3: Evaluation Form Unified Parkinson s Disease Rating
More informationTHYROID DISEASE IN CHILDREN
THYROID DISEASE IN CHILDREN Douglas G. Rogers, M.D. Center for Pediatric and Adolescent Endocrinology Cleveland Clinic Foundation Unfortunately neither I nor any immediate family members have any financial
More informationAdrenal Insufficiency. Adrenal cortex secretions. Adrenal Insufficiency. Adrenal Insufficiency. Acute Adrenal Insufficiency
Adrenal cortex secretions Cortisol secretion Diurnal pattern 24 hour secretion = Stress = demands 30 mg 300 mg to meet physiological Adrenal Insufficiency PRIMARY ADDISON S DISEASE Autoimmune Infection
More informationParkinson s disease. 14 June 2012
Parkinson s disease 14 June 2012 Cardinal sign of parkinsonism As least 2/4 for diagnosis Resting tremor Bradykinesia Rigidity Postural instability Classification Idiopathic Parkinson disease Secondary
More informationMotor Fluctuations in Parkinson s
Motor Fluctuations in Parkinson s What are motor fluctuations? Motor fluctuations are associated with longterm use of levodopa (trade names Sinemet or Madopar, Co-careldopa or Co-beneldopa), and usually
More informationCare Manager Resources: Common Questions & Answers about Treatments for Depression
Care Manager Resources: Common Questions & Answers about Treatments for Depression Questions about Medications 1. How do antidepressants work? Antidepressants help restore the correct balance of certain
More informationThyroid pathology in the Presence of antiviral treatment of chronic hepatitis C. Professor Nikitin Igor G Russian State Medical University MOSCOW
Thyroid pathology in the Presence of antiviral treatment of chronic hepatitis C Professor Nikitin Igor G Russian State Medical University MOSCOW The structure of the side effects associated with antiviral
More informationThyroid Problems after Childhood Cancer
Thyroid Problems after Childhood Cancer Some people who were treated for cancer during childhood may develop endocrine (hormone) problems as a result of changes in the function of a complex system of glands
More informationMultiple System Atrophy guide (http://www.msaweb.co.uk/msaguide.htm)
Multiple System Atrophy guide (http://www.msaweb.co.uk/msaguide.htm) Accessing information on Multiple System Atrophy (MSA) can be hard work. The Sarah Matheson Trust (SMT) produces a guide to MSA that
More informationThyroid Eye Disease. Anatomy: There are 6 muscles that move your eye.
Thyroid Eye Disease Your doctor thinks you have thyroid orbitopathy. This is an autoimmune condition where your body's immune system is producing factors that stimulate enlargement of the muscles that
More informationSLEEP AND PARKINSON S DISEASE
A Practical Guide on SLEEP AND PARKINSON S DISEASE MICHAELJFOX.ORG Introduction Many people with Parkinson s disease (PD) have trouble falling asleep or staying asleep at night. Some sleep problems are
More informationGraves disease in childhood Antithyroid drug therapy
83rd Annual Meeting of the ATA October 620, 203 Duration of antithyroid drugs treatment Disclosure Nothing to disclose Pr Juliane Léger Paediatric Endocrinology Department Paris Diderot University Hôpital
More informationDallas Neurosurgical and Spine Associates, P.A Patient Health History
Dallas Neurosurgical and Spine Associates, P.A Patient Health History DOB: Date: Reason for your visit (Chief complaint): Past Medical History Please check corresponding box if you have ever had any of
More informationManagement in the pre-hospital setting
Management in the pre-hospital setting Inflammation of the joints Two main types: Osteoarthritis - cartilage loss from wear and tear Rheumatoid arthritis - autoimmune disorder Affects all age groups,
More informationCLINICAL PRACTICE GUIDELINES FOR PHYSICAL THERAPY IN PATIENTS WITH PARKINSON'S DISEASE
CLINICAL PRACTICE GUIDELINES FOR PHYSICAL THERAPY IN PATIENTS WITH PARKINSON'S DISEASE Charbel MACARI Physical Therapist, AUBMC Master in Neurological Rehabilitation OUTLINE Definition, Epidemiology and
More informationMEDICATIONS AND PARKINSON'S DISEASE Cathi A.Thomas R.N., M.S.
MEDICATIONS AND PARKINSON'S DISEASE Cathi A.Thomas R.N., M.S. Medications to relieve or decrease symptoms of Parkinson s disease are an important and necessary part of care. For some people this may be
More informationMotor dysfunction 2: Spinal cord injury and subcortical motor disorders ANATOMY REVIEW: Basal Ganglia
Motor dysfunction 2: Spinal cord injury and subcortical motor disorders ANATOMY REVIEW: Basal Ganglia A group of subcortical nuclei caudate, putamen, globus pallidus Caudate & Putamen = Neostriatum caudate
More informationoptimal use of thyroid function tests (TFTs) to diagnose and monitor thyroid disease.
Guidance for Thyroid Function Testing in Primary Care in Lothian In July 2006 following a lengthy consultation process, a joint working group comprising representatives from the Association of Clinical
More informationA Manic Episode is defined by a distinct period during which there is an abnormally and persistently elevated, expansive, or irritable mood.
Bipolar disorder Bipolar (manic-depressive illness) is a recurrent mode disorder. The patient may feel stable at baseline level but experience recurrent shifts to an emotional high (mania or hypomania)
More informationNursing Care of Patients with Movement Disorders. Catholic Health 2 nd Annual Neurorehab Symposium November 1, 2014
Nursing Care of Patients with Movement Disorders Catholic Health 2 nd Annual Neurorehab Symposium November 1, 2014 Types of Movement Disorders Parkinson s disease Huntington s disease Dystonia Tremors
More informationAlcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol
Pharmacologic Effects of Alcohol Alcohol Withdrawal Kristi Theobald, Pharm.D., BCPS Therapeutics III Fall 2003 Inhibits glutamate receptor function (NMDA receptor) Inhibits excitatory neurotransmission
More informationManagement of Parkinson s disease and co-existent health problems is a long journey, requiring a multidisciplinary team approach.
Diagnosis and management of Parkinson s Disease Key points 1. 2. 3. 4. 5. 6. The diagnosis of Parkinson s disease is still based on careful history taking and clinical examination, despite ongoing advances
More informationPARKINSON'S DISEASE The Disorder and Current Therapy Copyright 2008, Daniel Kassicieh, D.O.
PARKINSON'S DISEASE The Disorder and Current Therapy Copyright 2008, Daniel Kassicieh, D.O. Parkinson's disease is a common neurologic disorder. It affects people of all ages and ethnic backgrounds and
More informationChapter 18 Drugs Used for Psychoses Learning Objectives Identify signs and symptoms of psychotic behavior Describe major indications for the use of
Chapter 18 Drugs Used for Psychoses Learning Objectives Identify signs and symptoms of psychotic behavior Describe major indications for the use of antipsychotic agents Identify common adverse effects
More informationDEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE
1 DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE ASSESSMENT/PROBLEM RECOGNITION 1. Did the staff and physician seek and document risk factors for depression and any history of depression? 2. Did staff
More informationJournal Club. Parkinsonismo iatrogeno
PROGETTO UNIVA 2013 Journal Club Parkinsonismo iatrogeno Pietro Gareri, MD, PhD Geriatra ASP Catanzaro Lamezia Terme 3 Luglio 2013 Drug-induced parkinsonism (DIP) was recognized in the early 1950s as a
More informationTSH. TSH is an integral part of a thyroid panel useful for the determination and potential differentiation of hypothyroidism.
TSH Background Thyroid hormone synthesis and secretion is regulated via a negative feed-back control system, which involves the hypothalamus, anterior pituitary, and the thyroid gland. Thyrotrophin-releasing
More informationAlcohol Withdrawal Syndrome & CIWA Assessment
Alcohol Withdrawal Syndrome & CIWA Assessment Alcohol Withdrawal Syndrome is a set of symptoms that can occur when an individual reduces or stops alcoholic consumption after long periods of use. Prolonged
More information4 Clinical Particulars
SUMMARY OF PRODUCT CHARACTERISTICS 1 Name of the Medicinal Product Procyclidine Syrup 5mg/5ml 2. Qualitative and Quantitative Composition Each 5ml dose contains 5mg Procyclidine Hydrochloride BP. 3. Pharmaceutical
More informationLewy body dementia Referral for a Diagnosis
THE Lewy Body society The more people who know, the fewer people who suffer Lewy body dementia Referral for a Diagnosis Lewy Body Dementias REFERRAL FOR A DIAGNOSIS In the UK people with all forms of dementia
More informationContemporary Psychiatric-Mental Health Nursing. Assessing the Effectiveness of Medications. Administering Medications
Contemporary Psychiatric-Mental Health Nursing Chapter 32 Psychopharmacologic Nursing Interventions Assessing the Effectiveness of Medications Include how well the medications are helping the client to
More informationThyroid-Stimulating Hormone (TSH)
Thyroid-Stimulating Hormone (TSH) Table of Contents Test Overview Why It Is Done How To Prepare How It Is Done How It Feels Risks Results What Affects the Test What To Think About References Credits Test
More informationCLINICAL GUIDELINE FOR THE NEONATAL MANAGEMENT OF INFANTS BORN TO MOTHERS WITH THYROID DISEASE 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR THE NEONATAL MANAGEMENT OF INFANTS BORN TO MOTHERS WITH THYROID DISEASE 1. Aim/Purpose of this Guideline 1.1. This guideline applies to Neonatal/Paediatric and Midwifery/Obstetric
More informationHow To Treat Aphasic Depression
Antipsychotic Use in Patients with Parkinson s Disease 단국의대 정신과 이석범 Difficulties in Parkinson's disease Motor symptoms Neuropsychiatric syndromes Severe Disability Cognitive impairment 2 Neuropsychiatric
More informationPart 1 of a 6-Part Series
Release Date: April 1, 2003. Termination Date: April 1, 2004. Estimated time to complete this 6-part newsletter series: 3.0 hours. For additional updates, go to www.projectsinknowledge.com Awake and Involved:
More informationPATIENT HISTORY FORM
PATIENT HISTORY FORM If you are new to the office, have not been seen in over one (1) year, or are returning for a new problem, please complete this form in full. If there have been any changes since your
More informationTreatments for Major Depression. Drug Treatments The two (2) classes of drugs that are typical antidepressants are:
Treatments for Major Depression Drug Treatments The two (2) classes of drugs that are typical antidepressants are: 1. 2. These 2 classes of drugs increase the amount of monoamine neurotransmitters through
More informationThorazine (chlorpromazine)
Generic name: Chlorpromazine Available strengths: 10 mg, 25 mg, 50 mg, 100 mg, 200 mg tablets; 100 mg/ml oral concentrate; 25 mg/ml injection Available in generic: Yes Drug class: First-generation (conventional)
More informationParkinson s Disease Symptoms Guide
Parkinson s Disease Symptoms Guide Some symptoms of Parkinson s disease (PD) are hard for even specialists to detect. Others are obvious even to an untrained eye. Parkinson s symptoms are different for
More informationParkinson Disease Levodopa-Induced Dyskinesia. Christopher Kenney, MD Novartis Pharmaceuticals
Parkinson Disease Levodopa-Induced Dyskinesia Christopher Kenney, MD Novartis Pharmaceuticals Disclosures Dr. Kenney is a full-time employee of Novartis Pharmaceuticals Corporation The opinions expressed
More informationAn Introduction to Lewy Body Dementia
An Introduction to Lewy Body Dementia A special publication for people newly diagnosed with Lewy body dementia and those still seeking answers. You don t have to face LBD alone. Increasing Knowledge Sharing
More informationDisorders Considered. A Brief Synopsis of Select Neurological Disorders. Neurological and Psychiatric Symptoms. Neurological Basis
Disorders Considered A Brief Synopsis of Select Neurological Disorders Four neurological disorders are examined to illustrate pathological conditions that can develop related to course material Myasthenia
More informationSUMMARY OF RECOMMENDATIONS
SUMMARY OF RECOMMENDATIONS FOR THE LONG- TERM TREATMENT OF RLS/WED from AN IRLSSG TASK FORCE Members of the Task Force Diego Garcia- Borreguero, MD, Madrid, Spain* Richard Allen, PhD, Baltimore, MD, USA*
More informationClinical and Therapeutic Cannabis Information. Written by Cannabis Training University (CTU) All rights reserved
Clinical and Therapeutic Cannabis Information Written by Cannabis Training University (CTU) All rights reserved Contents Introduction... 3 Chronic Pain... 6 Neuropathic Pain... 8 Movement Disorders...
More informationEBM Parkinson s Diseases
Parkinson s Diseases Version 1 Final Page 1 Document control Version history Version Date Comments 1e (draft) 30 March 2007 Comments from customer incorporated 1d (draft) 22 January 2007 Formatting 1c
More informationBenzodiazepines. And Sleeping Pills. Psychological Medicine
Benzodiazepines And Sleeping Pills Psychological Medicine Introduction Benzodiazepines are a type of medication prescribed by doctors for its therapeutic actions in various conditions such as stress and
More informationNHS FORTH VALLEY Thyroid Storm
NHS FORTH VALLEY Thyroid Storm Date of First Issue 01 August 2006 Approved 01 August 2006 Current Issue Date 1 st July 2016 Review Date 1 st July 2018 Version EQIA Yes 01/08/2010 Author / Contact Group
More informationA GUIDE FOR THE NEW PATIENT. supported by the Neurological Foundation
PARKINSON S A GUIDE FOR THE NEW PATIENT supported by the Neurological Foundation INTRODUCTION 1 Contents 1. Introduction 2. Parkinson s 3. The main symptoms of Parkinson s 6. What causes Parkinson s? 7.
More informationAdjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.
Shared Care Guideline for Prescription and monitoring of Naltrexone Hydrochloride in alcohol dependence Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist,
More informationRECOMMENDATIONS. INVESTIGATION AND MANAGEMENT OF PRIMARY THYROID DYSFUNCTION Clinical Practice Guideline April 2014
INVESTIGATION AND MANAGEMENT OF PRIMARY THYROID DYSFUNCTION Clinical Practice Guideline April 2014 OBJECTIVE Alberta clinicians optimize laboratory testing for the investigation and management of primary
More informationSummary of the risk management plan (RMP) for Rasagiline ratiopharm (rasagiline)
EMA/744222/2014 Summary of the risk management plan (RMP) for Rasagiline ratiopharm (rasagiline) This is a summary of the risk management plan (RMP) for Rasagiline ratiopharm, which details the measures
More informationParkinson s Disease: Factsheet
Parkinson s Disease: Factsheet Tower Hamlets Joint Strategic Needs Assessment 2010-2011 Executive Summary Parkinson s disease (PD) is a progressive neuro-degenerative condition that affects a person s
More informationDepression in Older Persons
Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression
More informationAcute management of Parkinson s
Acute management of Parkinson s Fife Parkinson s Service 2013 1 Contents 1. Introduction 2. On admission to hospital 3. If Patient has compromised swallow or is nil by mouth 4. Conversion charts if patient
More informationUnmet Needs for Parkinson s Disease Therapeutics
Unmet Needs for Parkinson s Disease Therapeutics Coalition Against Major Diseases & FDA Workshop October 20, 2014 Caroline M Tanner MD, PhD Director, Parkinson's Disease Research Education and Clinical
More informationTremor in the Elderly
UNDERSTANDING Tremor in the Elderly Tremor is an important and frequent symptom/sign in older patients requiring a logical approach to diagnosis. The clinician should know the different types of common
More informationSleep Difficulties. Insomnia. By Thomas Freedom, MD and Johan Samanta, MD
Sleep Difficulties By Thomas Freedom, MD and Johan Samanta, MD For most people, night is a time of rest and renewal; however, for many people with Parkinson s disease nighttime is a struggle to get the
More informationDiagnosing Parkinson s disease (PD) in
MedicineToday 2015; 16(1): 12-18 PEER REVIEWED FEATURE 2 CPD POINTS The clinical challenge of early Parkinson s disease SIMON J.G. LEWIS MB BCh, BSc, MRCP, FRACP, MD Early Parkinson s disease may be challenging
More informationCerebellum and Basal Ganglia
Cerebellum and Basal Ganglia 1 Contents Cerebellum and Basal Ganglia... 1 Introduction... 3 A brief review of cerebellar anatomy... 4 Basic Circuit... 4 Parallel and climbing fiber input has a very different
More informationNaltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance
Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance Introduction Indication/Licensing information: Naltrexone is licensed for use as an additional therapy, within
More informationHyperthyroidism INTRODUCTION. Overview. Introduction cont. Signs and Symptoms. Signs and Symptoms cont. Marisol Amaral Mona Ruiz Ulises Gonzalez
INTRODUCTION Hyperthyroidism Marisol Amaral Mona Ruiz Ulises Gonzalez What is Hyperthyroidism? It is the 2 nd most prevalent endocrine disorder. Grave s disease is the most common type of hyperthyroidism,
More informationParkinson s Disease: General Information
Parkinson s Disease: General Information Does PD come in stages? If so, how many stages? Hubert Fernandez, MD: Staging provides an artificial classification of a patient's illness severity but, in reality,
More informationTHYROID FUNCTION TESTS
Thyroid Stimulating Hormone (TSH): THYROID FUNCTION TESTS The thyroid stimulating hormone (TSH) assay measures the concentration of thyroid stimulating hormone in the serum. TSH assays have been classified
More informationF r e q u e n t l y A s k e d Q u e s t i o n s
Myasthenia Gravis Q: What is myasthenia gravis (MG)? A: Myasthenia gravis (meye-uhss- THEEN-ee-uh GRAV uhss) (MG) is an autoimmune disease that weakens the muscles. The name comes from Greek and Latin
More informationHow To Treat An Elderly Patient
1. Introduction/ Getting to know our Seniors a. Identify common concepts and key terms used when discussing geriatrics b. Distinguish between different venues of senior residence c. Advocate the necessity
More informationPrescription Drug Abuse
Prescription Drug Abuse Introduction Most people take medicines only for the reasons their health care providers prescribe them. But millions of people around the world have used prescription drugs for
More information